Organisational modes for Open Innovation in the bio-pharmaceutical industry: An exploratory analysis

[1]  V. Chiesa,et al.  Unravelling the Process from Closed to Open Innovation: Evidence from Mature, Asset-Intensive Industries , 2010 .

[2]  Daniel Tolstoy,et al.  Network resource combinations in the international venturing of small biotech firms , 2010 .

[3]  Yu-An Huang,et al.  R&D sourcing strategies: Determinants and consequences , 2009 .

[4]  Soumodip Sarkar,et al.  Dynamics of open innovation in the food industry , 2008 .

[5]  Stephen Roper,et al.  From capability to connectivity — absorptive capacity and exploratory alliances in biopharmaceutical firms: a US–Europe comparison , 2008 .

[6]  R. Smits,et al.  The role of users in innovation in the pharmaceutical industry. , 2008, Drug discovery today.

[7]  Davide Chiaroni,et al.  The knowledge-bridging role of Technical and Scientific Services in knowledge-intensive industries , 2008, Int. J. Technol. Manag..

[8]  J. West,et al.  Open innovation : researching a new paradigm , 2008 .

[9]  M. Perkmann,et al.  University Industry Relationships and Open Innovation: Towards a Research Agenda , 2007 .

[10]  G. Duysters,et al.  Networking as a Means to Strategy Change: The Case of Open Innovation in Mobile Telephony , 2007 .

[11]  Han van der Meer,et al.  Open Innovation – The Dutch Treat: Challenges in Thinking in Business Models , 2007 .

[12]  K. Reardon Courage as a skill. , 2007, Harvard business review.

[13]  Bernard H. Munos,et al.  Can open-source R&D reinvigorate drug research? , 2006, Nature Reviews Drug Discovery.

[14]  Cornelia Dröge,et al.  Collaborating for new product development: Selecting the partner with maximum potential to create value , 2006 .

[15]  W. Vanhaverbeke,et al.  Choosing Governance Modes for External Technology Sourcing , 2006 .

[16]  H. Chesbrough,et al.  Beyond High Tech: Early Adopters of Open Innovation in Other Industries , 2006 .

[17]  Oliver Gassmann,et al.  Opening Up the Innovation Process: Towards an Agenda , 2006 .

[18]  Dirk Voelkel,et al.  Managing Open Innovation in Biotechnology , 2006 .

[19]  Roland Ortt,et al.  Innovation management: different approaches to cope with the same trends , 2006, Int. J. Technol. Manag..

[20]  A. Salter,et al.  Open for innovation: the role of openness in explaining innovation performance among U.K. manufacturing firms , 2006 .

[21]  N. Sakkab,et al.  Connect and Develop : Inside Procter & Gamble's New Model for Innovation , 2006 .

[22]  Henry Chesbrough,et al.  Open Innovation: A research agenda , 2006 .

[23]  Jens Frøslev Christensen,et al.  The industrial dynamics of Open Innovation—Evidence from the transformation of consumer electronics , 2005 .

[24]  Ulrich Lichtenthaler,et al.  External Commercialization of Knowledge: Review and Research Agenda , 2005 .

[25]  Oliver Gassmann,et al.  Organizing Pharmaceutical Innovation: From Science‐based Knowledge Creators to Drug‐oriented Knowledge Brokers , 2005 .

[26]  Robert Kirschbaum,et al.  Open Innovation In Practice , 2005 .

[27]  Nader A. Salman,et al.  Indirect Networks: An Intangible Resource for Biotechnology Innovation , 2005 .

[28]  Davide Chiaroni,et al.  Industrial Clusters In Biotechnology , 2004 .

[29]  Zi-Lin He,et al.  Exploration vs. Exploitation: An Empirical Test of the Ambidexterity Hypothesis , 2004, Organ. Sci..

[30]  Eckhard Lichtenthaler,et al.  Organising the external technology exploitation process: current practices and future challenges , 2004, Int. J. Technol. Manag..

[31]  Ove Granstrand,et al.  The economics and management of technology trade: towards a pro-licensing era? , 2004, Int. J. Technol. Manag..

[32]  Georges Haour Resolving the Innovation Paradox , 2004 .

[33]  Georges Haour,et al.  Resolving the Innovation Paradox: Enhancing Growth in Technology Companies , 2003 .

[34]  J. Niosi Alliances are not enough explaining rapid growth in biotechnology firms , 2003 .

[35]  Henry Chesbrough,et al.  Open Innovation: The New Imperative for Creating and Profiting from Technology , 2003 .

[36]  V. Chiesa,et al.  La bioindustria - strategie competitive e organizzazione industriale nel settore delle biotecnologie farmaceutiche , 2003 .

[37]  Giuseppe Giardina,et al.  INNOVAZIONI NEI PROCESSI DI RICERCA IN CAMPO FARMACEUTICO , 2003 .

[38]  Hildy Teegen,et al.  Factors affecting foreign R&D location decisions: management and host policy implications , 2003, Int. J. Technol. Manag..

[39]  Kenneth W. Koput,et al.  The Spatial Clustering of Science and Capital: Accounting for Biotech Firm-Venture Capital Relationships , 2002 .

[40]  Walter W. Powell,et al.  A Comparison of U.S. and European University-Industry Relations in the Life Sciences , 2001 .

[41]  E. Roberts Benchmarking Global Strategic Management of Technology , 2001 .

[42]  Vittorio Chiesa,et al.  R&D Strategy and Organisation:Managing Technical Change in Dynamic Contexts , 2001 .

[43]  Anoop Madhok,et al.  The International Biotechnology Industry: A Dynamic Capabilities Perspective , 2000 .

[44]  Joel A. C. Baum,et al.  Don't go it alone: alliance network composition and startups' performance in Canadian biotechnology , 2000 .

[45]  David L. Deeds,et al.  The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry , 1999 .

[46]  David Wilemon,et al.  Changing patterns in industrial R&D management , 1996 .

[47]  Deb Chatterji,et al.  Accessing External Sources of Technology , 1996 .

[48]  W. Powell,et al.  Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .

[49]  J. Davidson,et al.  Quality deployment in R&D organizations , 1996 .

[50]  Barry L. Bayus,et al.  Are Product Life Cycles Really Getting Shorter , 1994 .

[51]  J. March Exploration and exploitation in organizational learning , 1991, STUDI ORGANIZZATIVI.

[52]  A. Pettigrew Longitudinal Field Research on Change: Theory and Practice , 1990 .

[53]  Mark S. Granovetter The Strength of Weak Ties , 1973, American Journal of Sociology.